Dwight D Koeberl Selected Research

IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)

1/2019	Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.
5/2016	Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
5/2014	Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.
1/2013	Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
6/2011	Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
11/2010	Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dwight D Koeberl Research Topics

Disease

33	Glycogen Storage Disease Type II (Pompe's Disease) 01/2021 - 04/2003
17	Hepatorenal form of glycogen storage disease 01/2020 - 07/2007
11	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 07/2007
7	Glycogen Storage Disease Type I 01/2019 - 07/2007
4	Glycogen Storage Disease (Glycogenosis) 01/2020 - 11/2012
3	Muscular Diseases (Myopathy) 01/2020 - 09/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 11/2007
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2017
3	Seizures (Absence Seizure) 05/2018 - 08/2003
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 11/2005
2	Hypertrophy 01/2020 - 05/2016
2	Lactic Acidosis 01/2020 - 09/2015
2	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2020 - 11/2007
2	Spasm (Spasms) 01/2020 - 01/2018
2	Tremor (Tremors) 01/2020 - 01/2018
2	Guanidinoacetate methyltransferase deficiency 05/2018 - 06/2013
2	Weight Gain 02/2016 - 06/2013
2	Hepatocellular Carcinoma (Hepatoma) 02/2016 - 08/2009
2	Muscle Weakness 02/2016 - 11/2005
2	Adenoma (Adenomas) 08/2009 - 11/2007
2	Short chain Acyl CoA dehydrogenase deficiency 11/2003 - 08/2003
1	Hemolytic Anemia 01/2022
1	Hemiplegia (Spastic Hemiplegia) 01/2021
1	Fabry Disease (Fabry's Disease) 01/2020
1	Hypertriglyceridemia 01/2020
1	Fatty Liver 01/2020
1	Neoplasms (Cancer) 12/2019
1	Urolithiasis 11/2018
1	Movement Disorders (Movement Disorder) 05/2018
1	Muscle Hypotonia (Hypotonia) 01/2018
1	Ataxia (Dyssynergia) 01/2018
1	Disease Progression 01/2018
1	Cardiomegaly (Heart Hypertrophy) 11/2017
1	Tachycardia (Tachyarrhythmias) 06/2017
1	Nausea 06/2017
1	Liver Failure 02/2016
1	Homocystinuria 01/2016
1	Acidosis 09/2015
1	Hemophilia B (Haemophilia B) 03/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015

Drug/Important Bio-Agent (IBA)

23	AcidsIBA 01/2021 - 04/2003
21	GlycogenIBA 01/2021 - 01/2005
14	EnzymesIBA 01/2021 - 12/2006
14	GlucosidasesIBA 06/2020 - 11/2010
12	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2020 - 07/2007
8	alpha-Glucosidases (Acid Maltase)IBA 01/2021 - 04/2003
8	human GAA protein (Myozyme)FDA Link 01/2021 - 12/2008
6	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2019 - 11/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2008
5	ClenbuterolIBA 01/2018 - 06/2011
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2020 - 02/2012
4	CationsIBA 01/2019 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2002
2	Liver GlycogenIBA 01/2020 - 11/2012
2	LipidsIBA 01/2020 - 02/2016
2	Insulin-Like PeptidesIBA 01/2020 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2005
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 02/2016
2	BezafibrateIBA 06/2019 - 01/2019
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 05/2016
2	Glucose-6-PhosphateIBA 01/2019 - 02/2016
2	CreatineIBA 05/2018 - 01/2018
2	Guanidinoacetate N-Methyltransferase (Guanidinoacetate Methyltransferase)IBA 05/2018 - 06/2013
2	glycocyamineIBA 05/2018 - 06/2013
2	Carnitine (L-Carnitine)FDA LinkGeneric 09/2015 - 08/2003
2	AntibodiesIBA 03/2015 - 02/2010
2	HepcidinsIBA 05/2010 - 04/2010
2	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 11/2003 - 08/2003
2	acylcarnitineIBA 11/2003 - 08/2003
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	GalactosidasesIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Losartan (Cozaar)FDA LinkGeneric 01/2020
1	globotriaosyl lysosphingolipidIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Fenofibrate (CiL)FDA LinkGeneric 01/2020
1	globotriaosylceramide (globotriosylceramide)IBA 01/2020
1	Carvedilol (Coreg)FDA LinkGeneric 01/2020
1	Fetal Proteins (Fetoprotein)IBA 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 12/2019
1	2- ((3,5- dimethyl- 4- (4'- hydroxy- 3'- isopropylbenzyl)phenoxy)methyl)- 4- (3- chlorophenyl)- 2- oxido(1,3,2)dioxaphosphonaneIBA 01/2019
1	Calcium OxalateIBA 11/2018
1	calcium phosphateIBA 11/2018
1	MM Form Creatine KinaseIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 01/2018
1	CarbohydratesIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2016
1	Zinc Finger NucleasesIBA 04/2016
1	CystathionineIBA 01/2016
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 09/2015
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2015

Therapy/Procedure

21	Therapeutics 01/2021 - 11/2010
17	Enzyme Replacement Therapy 01/2020 - 11/2007
2	Injections 01/2021 - 02/2012
2	Liver Transplantation 09/2009 - 11/2007
1	Contraindications 01/2020